Generation and characterization of fourteen induced pluripotent stem cell (iPSC) lines derived from endometrial stromal fibroblasts of women with polyendocrine metabolic ovarian syndrome (PMOS) (n = 7) and non-PMOS controls (n = 7)

This publication has 12 references indexed in Scilit:

• From Gene Function to Precision Intervention: CRISPR/Cas9 and Stem Cell-Based Strategies as Emerging Disease-Modifying Approaches in PMOS
  Stem Cell Reviews and Reports, 2026
• Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process
  The Lancet, 2026
• PCOS endometrium-derived epithelial organoids as a novel model to study endometrial dysfunction
  Human Reproduction, 2025
• CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells
  Stem Cell Reports, 2022
• Decidualized endometrial stromal cells present with altered androgen response in PCOS
  Scientific Reports, 2021
• Progesterone triggers Rho kinase-cofilin axis during in vitro and in vivo endometrial decidualization
  Human Reproduction, 2021
• Reprogramming of Fibroblasts to Human iPSCs by CRISPR Activators
  2020
• Women with polycystic ovary syndrome present with altered endometrial expression of stanniocalcin-1†
  Biology of Reproduction, 2019
• Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro
  Human Reproduction, 2015
• Mesenchymal Stem/Progenitors and Other Endometrial Cell Types From Women With Polycystic Ovary Syndrome (PCOS) Display Inflammatory and Oncogenic Potential
  The Journal of Clinical Endocrinology & Metabolism, 2013